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SUMMARY 12 
Sleep is an essential and evolutionarily conserved behavioral state whose regulation remains 13 
poorly understood. To identify genes that regulate vertebrate sleep, we recently performed a 14 
genetic screen in zebrafish, and here we report the identification of neuropeptide Y (NPY) as both 15 
necessary for normal daytime sleep levels and sufficient to promote sleep. We show that 16 
overexpression of NPY increases sleep, whereas mutation of npy or ablation of npy-expressing 17 
neurons decreases sleep. By analyzing sleep architecture, we show that NPY regulates sleep 18 
levels primarily by modulating the length of wake bouts. To determine how NPY regulates sleep, 19 
we tested for interactions with several systems known to regulate sleep, and provide anatomical, 20 
molecular, genetic and pharmacological evidence that NPY promotes sleep by inhibiting 21 
noradrenergic signaling. These data establish NPY as an important vertebrate sleep/wake 22 
regulator and link NPY signaling to an established arousal-promoting system. 23 
 24 
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HIGHLIGHTS: 28 
- A genetic screen in zebrafish shows that overexpression of NPY promotes sleep 29 
- Mutation of npy or ablation of npy-expressing neurons results in decreased sleep 30 
- NPY regulates sleep levels primarily by modulating the length of wake bouts 31 
- NPY promotes sleep by inhibiting noradrenergic signaling 32 
 33 
eTOC Blurb 34 
Based on a genetic screen, Singh et al identify NPY signaling and npy-expressing neurons as 35 
regulators of zebrafish sleep. They show that NPY promotes sleep by inhibiting noradrenergic 36 
signaling, thus linking NPY signaling to an established arousal-promoting system.  37 
 3 
INTRODUCTION 38 
Sleep is among most basic needs of living organisms, yet mechanisms that regulate sleep remain 39 
poorly understood. Several neuropeptides have been implicated in regulating mammalian sleep 40 
[1], including hypocretin [2-4], which promotes wakefulness, and galanin [5-8] and melanin 41 
concentrating hormone [9-12], which promote sleep, suggesting that examining additional 42 
neuropeptides may be a fruitful approach to identify novel mechanisms that regulate sleep. 43 
Identifying these mechanisms using mammalian model systems has been challenging due to their 44 
poor amenability for large-scale screens, although such screens are possible [13]. As an 45 
alternative approach, several groups have used behavioral criteria to study sleep-like states in 46 
simpler model organisms that are amenable to screens, including Drosophila [14, 15], C. elegans 47 
[16, 17], and zebrafish [18-20]. In particular, several groups have demonstrated behavioral, 48 
anatomical, genetic and pharmacological conservation of sleep between zebrafish and mammals, 49 
establishing zebrafish as a simple and inexpensive vertebrate sleep model [18-24]. We previously 50 
described a novel approach that we used to screen for genes whose overexpression affects 51 
zebrafish sleep, and reported that the neuropeptide neuromedin U is both necessary and 52 
sufficient for normal levels of arousal [25]. Here we demonstrate that another neuropeptide 53 
identified in the screen, neuropeptide Y (NPY), is both necessary for daytime sleep and sufficient 54 
to promote sleep. 55 
 56 
NPY is widely expressed in the brain and has been implicated in regulating several endocrine, 57 
behavioral and circadian processes in mammals (reviewed in [26]). NPY is perhaps best known 58 
for its role in promoting feeding [27-30]. NPY has also been shown to affect sleep, but its role in 59 
this behavioral state remains unclear. Several studies showed that injection of in vitro synthesized 60 
NPY into the rodent brain [31-37] or intravenously in young healthy [38] or depressed  [39] human 61 
subjects can induce sleep or reduce locomotor activity. However, other rodent studies reported 62 
the opposite effect [40-42]. The basis for these disparate reports is unclear, but may be due to 63 
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different sites and doses of NPY injection, or the use of in vitro synthesized peptide that may vary 64 
in different preparations and from endogenously produced NPY. Understanding the role of NPY 65 
in mammalian sleep is also confounded by extensive links between mechanisms that regulate 66 
feeding and sleep [40-43]. Indeed, the wake-promoting effect of injected NPY is associated with 67 
increased feeding [40-42], suggesting that the increase in wakefulness may be an indirect effect 68 
of NPY on feeding. npy mutant mice exhibit several phenotypes, including increased anxiety in 69 
the open field test, depression-like behavior in the forced swim test, and cognitive deficits in the 70 
Morris water maze [44, 45], and are less susceptible to diet-induced obesity as a result of reduced 71 
feeding and increased energy expenditure [46]. However, an analysis of sleep in these animals 72 
and a role for npy-expressing neurons in sleep has not been described. As a result, despite 73 
decades of study, the role of NPY in vertebrate sleep remains unclear. 74 
 75 
Here we use a genetic screen and follow-up gain-of-function genetic studies to show that NPY is 76 
sufficient to promote sleep in zebrafish. Using an npy mutant and chemogenetic ablation of npy-77 
expressing neurons, we also show that endogenous npy and npy-expressing neurons are 78 
necessary for normal daytime sleep levels. Finally, we show that NPY promotes sleep by inhibiting 79 
the wake-promoting noradrenergic system, thus providing a mechanistic basis for the regulation 80 
of sleep by NPY. Taken together with the requirement of noradrenergic signaling for the wake-81 
promoting function of hypocretin [47, 48], these results suggest that the noradrenergic system 82 
integrates neuropeptidergic signals that regulate sleep/wake states. 83 
 84 
RESULTS 85 
Overexpression of human NPY reduces locomotor activity and increases sleep in zebrafish 86 
larvae 87 
We recently performed a genetic overexpression screen to identify genes that affect larval 88 
zebrafish sleep and wakefulness [25]. In the primary screen, we injected over 1200 unique 89 
 5 
plasmids in which a heat shock-inducible promoter (hsp) regulates the expression of genes that 90 
encode for secreted proteins into wild-type (WT) zebrafish embryos at the one-cell stage. We 91 
used a collection of human open reading frames (ORFs) encoding secreted proteins from the 92 
hORFeome 3.1 library [49] because a resource of zebrafish ORFs was not available. Co-injection 93 
of each plasmid with tol2 transposase mRNA resulted in efficient incorporation of the hsp 94 
regulated transgene into the genome in many cells of each animal and enabled heat shock-95 
induced overexpression [25]. We then compared sleep/wake behaviors in injected animals before 96 
and after heat shock and to negative control animals injected with a hsp:egfp plasmid. One gene 97 
whose overexpression increased sleep at night (Z-score=1.8) encoded human NPY (Figure 98 
S1A). Even though zebrafish larvae normally exhibit high levels of sleep at night, we found that 99 
overexpression of human NPY caused a further 28% decrease in locomotor activity and 34% 100 
increase in sleep compared to control animals during the night following heat shock (P<0.05 and 101 
P<0.01, two-tailed Student’s t test) (Figures S1B-S1G). We observed a similar phenotype during 102 
the day before heat shock that did not reach statistical significance, consistent with leaky 103 
expression from the hsp promoter that often is observed using this transient injection assay, but 104 
is not observed using stable transgenic lines [25]. 105 
 106 
Overexpression of zebrafish NPY reduces locomotor activity and increases sleep in 107 
zebrafish larvae 108 
Based on the human NPY overexpression phenotype, we investigated the role of the zebrafish 109 
npy orthologue in sleep. Using reciprocal BLAST searches, we identified a single npy ortholog in 110 
the zebrafish genome, which encodes for a preproprotein that generates a predicted 36 amino-111 
acid mature peptide that is 89% identical to the mature peptide of human and mouse NPY (Figure 112 
S1H). npy is widely expressed in the mammalian brain, particularly in the hypothalamus, 113 
amygdala, locus coeruleus (LC) and cerebral cortex [50, 51]. Using in situ hybridization (ISH) with 114 
an npy-specific probe, immunostaining for total extracellular signal-regulated kinase (t-ERK), and 115 
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registration of images to the Z-brain atlas [52], we found that npy is similarly expressed in several 116 
discrete nuclei within the larval zebrafish brain. These include the olfactory bulb, telencephalon, 117 
preoptic area, posterior tuberculum, intermediate lateral hypothalamus, caudal medial 118 
hypothalamus, pretectum, torus semicircularis, tectum, LC, medial rhombomere and subpallium 119 
(Figures S1I–S1N and Video S1). We also observed npy expression in the retina (data not 120 
shown) but not in other tissues. 121 
 122 
To test whether overexpression of zebrafish NPY affects sleep in zebrafish, we generated 123 
Tg(hsp:npy) stable transgenic zebrafish. We observed that Tg(hsp:npy) animals and their WT 124 
siblings exhibited similar levels of locomotor activity and sleep before heat-shock (Figures 1A-125 
1D). However, following a heat shock at 3 p.m., Tg(hsp:npy) animals were 50% less active 126 
(Figures 1A and 1B) and slept 111% more (Figures 1C and 1D) than their WT siblings for the 127 
rest of the day (both P<0.0001, two-tailed Student’s t test). The phenotype resulted from a 230% 128 
increase in the number of sleep bouts (Figure 1E) and an 85% decrease in the length of wake 129 
bouts (Figure 1G) (both P<0.0001, two-tailed Student’s t test), with a smaller decrease in the 130 
length of sleep bouts (Figure 1F), and thus is primarily due to fragmentation of the wake state. 131 
 132 
The increase in sleep after the heat shock-induced pulse of NPY overexpression was dampened 133 
by nighttime. A previous study showed that the circadian system inhibits sleep in the evening, 134 
when homeostatic sleep drive is high [53], suggesting the circadian system might limit NPY 135 
overexpression-induced sleep to the day. To test whether NPY overexpression can also increase 136 
sleep at night, we heat shocked animals during the last hour of the day. We found that Tg(hsp:npy) 137 
animals were 46% less active (Figures S2A-S2C) and slept 54% more (Figures S2D-S2F) than 138 
their WT siblings during the night (both P<0.0001, two-tailed Student’s t test), similar to the 139 
daytime phenotype when NPY overexpression was induced in the afternoon. The nighttime 140 
phenotype was due to an increase in the length of sleep bouts (Figure S2H) and a decrease in 141 
 7 
the length of wake bouts (Figure S2J). Unlike NPY overexpression induced during the afternoon, 142 
there was no change in the number of sleep bouts (Figure S2G). These observations suggest 143 
that dampening of the NPY overexpression phenotype at night following heat shock in the 144 
afternoon is due to declining levels of overexpressed NPY rather than effects of the circadian 145 
clock on NPY function. 146 
 147 
Light affects locomotor activity and sleep in zebrafish [19, 20], as it does in mammals [54]. To 148 
determine whether light affects NPY overexpression-induced sleep, we entrained larvae by 149 
raising them in 14:10 hour light:dark (LD) conditions for four days, and then transferred them to 150 
constant dark before inducing NPY overexpression. Overexpression of NPY decreased locomotor 151 
activity by 54% (Figures S2K and S2L) and increased sleep by 80% (Figures S2M and S2N) 152 
during the rest of the subjective day compared to WT siblings (both P<0.0001, two-tailed Student’s 153 
t test). This phenotype was due to an increase in the number of sleep bouts (Figure S2O) and a 154 
decrease in the length of wake bouts (Figure S2Q), with no change in the length of sleep bouts 155 
(Figure S2P). Hence, NPY overexpression promotes sleep independent of lighting condition and 156 
circadian phase. 157 
 158 
Overexpression of zebrafish NPY increases arousal threshold in zebrafish larvae 159 
Sleep is distinguished from quiet wakefulness by reduced responsiveness to stimuli [55]. Because 160 
NPY overexpression increases sleep, we asked whether it also alters arousal threshold. To do 161 
so, we delivered mechano-acoustic tapping stimuli of variable intensities every minute to larvae 162 
after overexpression of NPY and monitored their behavioral responses. We found that the 163 
effective tap intensity at which we observed the half-maximal response (effective tap power 50, 164 
ETP50) for Tg(hsp:npy) was 290% higher than their WT siblings (Figure 1H) (P<0.05 by extra 165 
sum-of-squares F test). Thus, NPY overexpression increases arousal threshold, consistent with 166 
a sleep state. We next asked if overexpression of NPY affects arousal in awake and/or sleeping 167 
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larvae. To do so, we delivered tapping stimuli at three tap powers of 2.3, 3.0 and 4.0 arbitrary 168 
units, which were lower than the ETP50 of both Tg(hsp:npy) and WT siblings. We allowed 5 169 
minutes between trials and, according to the behavioral definition of sleep, scored animals as 170 
awake if they moved during the minute before a tap stimulus. We found that NPY overexpressing 171 
animals were significantly less responsive to these stimuli compared to their WT siblings during 172 
both awake (Figure 1I) (all intensities P<0.0001, two-tailed Student’s t test), and sleep (Figure 173 
1J) (P<0.05, P<0.01 and P<0.001 for 2.3, 3.0 and 4.0 tap powers, respectively, two-tailed 174 
Student’s t test) states. These data suggest that NPY overexpression decreases arousal in awake 175 
animals and increases sleep depth in sleeping animals. 176 
 177 
npy mutant zebrafish are more active and sleep less during the day 178 
Having shown that overexpression of NPY is sufficient to promote sleep, we next asked whether 179 
endogenous npy is required for normal sleep/wake behaviors. To do so, we used the zinc finger 180 
nuclease method to generate zebrafish containing a predicted null mutation in the npy open 181 
reading frame [56]. We isolated a zebrafish line containing a 17-nucleotide deletion in the second 182 
exon of the npy gene [56], which results in a translational frame shift at the beginning of the mature 183 
peptide domain (Figure 2A), generating a protein that lacks the mature peptide domain and thus 184 
is likely nonfunctional. These homozygous mutant animals are viable and fertile, and lack obvious 185 
developmental defects. 186 
 187 
Consistent with the NPY overexpression phenotype, npy-/- larvae were 23% more active and 188 
slept 36% less during the day than their npy+/+ siblings (P<0.0001 and P<0.01, one-way ANOVA, 189 
Holm-Sidak test) (Figures 2B, 2C, 2E and 2F). These effects were due to a decrease in the 190 
number of sleep bouts (Figure 2H) and an increase in the length of wake bouts (Figure 2L), with 191 
no effect on the length of sleep bouts (Figures 2J). Thus, reduced daytime sleep in npy-/- animals 192 
is due to consolidation of the wake state. We did not observe sleep/wake phenotypes in npy-/- 193 
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animals at night. These data indicate that endogenous npy is required for normal daytime sleep 194 
levels. 195 
 196 
Previous studies showed that microinjection of NPY into the suprachiasmatic nucleus (SCN) of 197 
the hamster hypothalamus phase shifts the locomotor activity circadian rhythm in constant light 198 
(LL) [57, 58], suggesting that NPY may regulate entrainment or expression of circadian rhythms. 199 
To test whether endogenous npy is required for circadian regulation of locomotor activity and 200 
sleep, we tested larvae that were entrained for 4 days in LD, then monitored for 24 hours in LD 201 
and then for 48 hours after a shift to LL. Absence of npy had no obvious effect on the locomotor 202 
activity or sleep circadian period length or phase (Figures 3A and 3D). As expected, in LD npy-203 
/- animals were more active (Figures 3A and S3A) and slept less (Figures 3D and S3C) than 204 
their npy+/+ and npy+/- siblings during the day, with no phenotype at night. The daytime 205 
phenotype was due to fewer sleep bouts and longer wake bouts (Figures S3E and S3I). Following 206 
the shift to LL, npy-/- animals were more active by 30% and 26% during the subjective day and 207 
night, respectively, compared to their npy+/+ siblings (P<0.001 and P<0.01, one-way ANOVA, 208 
Holm-Sidak test) (Figures 3A-3C). npy-/- larvae also slept ~40% less during the subjective day 209 
and night (P<0.0001 and P<0.001, one-way ANOVA, Holm-Sidak test) (Figures 3D-3F). These 210 
phenotypes were primarily due to longer wake bouts (Figures 3K and 3L), although there were 211 
also fewer (Figures 3G and 3H) and shorter (Figures 3I and 3J) sleep bouts. These results 212 
indicate that npy is not required for circadian regulation of locomotor activity or sleep in zebrafish 213 
larvae, but rather regulates sleep in a light-dependent manner. 214 
 215 
Ablation of npy-expressing neurons increases locomotor activity and decreases sleep 216 
As an alternative approach to test the hypothesis that NPY is necessary for normal sleep levels, 217 
we used a chemogenetic approach to specifically ablate npy-expressing neurons. To this end, we 218 
used BAC recombineering [59] to insert an optimized version of the transcriptional activator Gal4 219 
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(KalTA4) at the npy start codon of a BAC containing 290 kb of genomic sequence that includes 220 
the npy gene. We then used Tol2-mediated transgenesis to generate Tg(npy:kalta4) zebrafish. 221 
To determine the specificity of this transgenic line, we performed double fluorescent ISH (FISH) 222 
using probes specific for npy and kalta4. We observed that, depending on the brain region, kalta4 223 
is expressed in >80% of npy-expressing neurons (>95% for some nuclei), and that >92% of 224 
kalta4-expressing neurons also express npy (Figure S5A and Table S1). To ablate these 225 
neurons, we mated these fish to Tg(uas:nfsb-mcherry) animals [60], resulting in the expression 226 
of nitroreductase (nfsb) in npy-expressing neurons (Figure 4A). Nitroreductase is a bacterial 227 
protein that converts the inert prodrug metronidazole (MTZ) into a cytotoxic DNA crosslinking 228 
agent, thus enabling drug-inducible ablation of the targeted cell type [61]. Tg(npy:kalta4); 229 
Tg(uas:nfsb-mcherry) and Tg(npy:kalta4) sibling controls were treated with MTZ or DMSO vehicle 230 
control for 48 hours (from 3 days post-fertilization (dpf) to 5 dpf), which resulted in an almost 231 
complete elimination of mCherry-labeled cells in double transgenic animals treated with MTZ 232 
compared to DMSO (Figures 4A-4C), indicating the loss of most npy-expressing neurons. 233 
Consistent with these observations, we detected extensive TUNEL labeling in npy-expressing 234 
neurons in Tg(npy:kalta4);Tg(uas:nfsb-mcherry) larvae treated with MTZ, but not in those treated 235 
with DMSO (Figures S5B-S5D), indicating that MTZ treatment induces apoptosis of npy-236 
expressing neurons. Consistent with the npy-/- phenotype, we found that ablation of npy-237 
expressing neurons caused a 23% increase in locomotor activity (Figures 4C and 4D) and a 28% 238 
decrease in sleep (Figures 4F and 4G) (P<0.01 and P<0.05, two-tailed Student’s t test) 239 
compared to sibling controls during the day. This phenotype was due to a decrease in the number 240 
of sleep bouts (Figure 4I) and an increase in the length of wake bouts (Figure 4M), indicating 241 
consolidation of the wake state, similar to npy-/- animals. To confirm that the Tg(uas:nfsb-242 
mcherry) transgene does not induce a behavioral phenotype in the absence of Tg(npy:kalta4), we 243 
crossed Tg(npy:kalta4)/+;Tg(uas:nfsb-mcherry)/+ to WT fish, excluded animals that were positive 244 
for mCherry, and treated the remaining animals with MTZ. We observed no difference in 245 
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locomotor activity or sleep levels among animals of these three genotypes (Figure S4). The cell 246 
ablation phenotype was slightly weaker than that of the npy mutant, likely because the npy:kalta4 247 
transgene is not expressed in all npy-expressing neurons. A caveat to this experiment is that a 248 
small number of neurons express kalta4 but not npy in some brain regions (8% of KalTA4-positive 249 
cells in the subpallium, <5% of KalTA4-positive cells in other brain regions; Figure S5A and Table 250 
S1). As a result, it is possible that ablation of these NPY-negative cells is responsible for the 251 
behavioral phenotype. However, this is unlikely to be the case due to the small number of cells 252 
involved and because the NPY neuron ablation phenotype is consistent with the npy mutant 253 
phenotype, suggesting that both NPY and npy-expressing neurons are necessary for normal 254 
daytime sleep levels. 255 
 256 
The NPY overexpression phenotype is not blocked by manipulation of several pathways 257 
known to regulate sleep 258 
To identify genetic mechanisms through which NPY affects sleep, we tested whether the NPY 259 
overexpression phenotype is suppressed in zebrafish containing mutations in other genes 260 
implicated in regulating sleep (Table S2). We found that the NPY overexpression phenotype 261 
persisted in larvae containing null mutations in histidine decarboxylase (hdc) [62], hypocretin 262 
receptor (hcrtr) [19], corticotropin releasing hormone a (crha) (Singh et al., unpublished), crhb 263 
(Singh et al., unpublished) or arylalkylamine N-acetyltransferase 2 (aanat2) [63] (data not shown). 264 
These data suggest that NPY promotes sleep via other mechanisms. 265 
 266 
NPY promotes sleep by inhibiting noradrenergic signaling 267 
Pharmacological and genetic studies in mammals and zebrafish have shown that norepinephrine 268 
(NE) plays an important role in promoting arousal [48, 64], and the brainstem LC is the primary 269 
source of NE in the brain [65]. We obtained several lines of evidence suggesting that NPY 270 
promotes sleep by inhibiting NE signaling. First, a nucleus of 3-5 npy-expressing neurons is 271 
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located adjacent to, and sends projections that form close contacts with, LC neurons (Figures 272 
5A-5H and Video S2).  While this observation does not prove a direct interaction between the 273 
two neuronal populations, it is consistent with our functional evidence that NPY promotes sleep 274 
by inhibiting NE signaling (see below). The zebrafish genome contains at least seven npy receptor 275 
genes [66]. To determine if one or more of these receptors is expressed in LC neurons, we 276 
performed FISH using probes specific for each receptor in Tg(dbh:EGFP) larvae [67], whose LC 277 
neurons express EGFP. We did not detect expression of any npy receptor in LC neurons, although 278 
we observed expression of npy receptor y1 (npyr1) (Figure 5I) and npy receptor y2 like (npyr2l) 279 
(Figure 5J) in cells near the LC. The other npy receptors either showed specific expression in 280 
other brain regions (npyr8a and npyr8b) or no detectable specific pattern of expression (npyr2, 281 
npyr4 and npyr7) (data not shown). These results suggest that NPY may indirectly affect NE 282 
signaling, although it remains possible that a npy receptor is expressed in LC neurons at levels 283 
too low to be detected using FISH, a common problem for G-protein coupled receptors (GPCRs), 284 
the protein class of NPY receptors. 285 
 286 
Second, we found that the sedating effects of NPY overexpression and loss of NE signaling are 287 
not additive. We made this observation by overexpressing NPY in larvae that lack NE synthesis 288 
due to mutation of dopamine beta hydroxylase (dbh) [48], or that lack NE signaling due to 289 
treatment with the α-1-adrenergic receptor antagonist prazosin. Both genetic and 290 
pharmacological inhibition of NE signaling increase sleep in zebrafish larvae [48]. If NPY 291 
promotes sleep by inhibiting NE signaling, then overexpression of NPY should not further increase 292 
sleep in dbh-/- larvae or in WT larvae treated with prazosin. Alternatively, if NPY promotes sleep 293 
via a NE-independent mechanism, then the combined effects of NPY overexpression and loss of 294 
NE signaling on sleep should be additive. Because the behavior of dbh+/- animals is 295 
indistinguishable from that of their dbh+/+ siblings [48], we compared dbh+/- and dbh-/- siblings 296 
to reduce the number of comparisons in each experiment, and thus increase the number of 297 
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animals per condition. Prior to heat shock-induced NPY overexpression, dbh-/- larvae were 40% 298 
less active and slept over 100% more than their dbh+/- siblings for both Tg(hsp:npy) larvae and 299 
their non-transgenic siblings (Figures 6A-6D) (both: P<0.01, two-way ANOVA, Holm-Sidak test). 300 
Overexpression of NPY decreased locomotor activity by 54% and increased sleep by 60% in 301 
Tg(hsp:npy);dbh+/- larvae compared their dbh+/- siblings (Figures 6A-6D) (P<0.0001 and 302 
P<0.05, Two-way ANOVA, Holm-Sidak test). However, overexpression of NPY did not further 303 
affect the sleep/wake behavior of dbh-/- larvae, as locomotor activity and sleep levels were 304 
indistinguishable for Tg(hsp:npy);dbh-/- and dbh-/- larvae (Figures 6A-6D). We obtained similar 305 
results for NPY overexpression in prazosin-treated larvae to compared to DMSO vehicle-treated 306 
controls (Figures S6A-S6D). To confirm that the failure of NPY overexpression to enhance sleep 307 
in dbh-/- or prazosin-treated animals is not due to a ceiling effect for sleep, we found that treatment 308 
with melatonin, an alternative sedative, enhanced sleep induced by overexpression of NPY 309 
(Figures S7A-S7D) or prazosin (Figures S7E-S7H). 310 
 311 
Third, we found that the increased locomotor activity and reduced sleep observed in npy-/- 312 
animals compared to their npy+/+ siblings was abolished by treatment with prazosin. We made 313 
this observation by treating npy+/+, npy+/- and npy-/- larvae with either DMSO or prazosin. If NPY 314 
promotes sleep by inhibiting NE signaling, then loss of NPY should not affect prasozin-induced 315 
sleep. Alternatively, if NPY promotes sleep via a NE-independent mechanism, then loss of NPY 316 
should affect sleep amount in prazosin-treated animals. Consistent with the former possibility, we 317 
found that prazosin decreased locomotor activity and increased sleep, and this phenotype was 318 
indistinguishable for npy+/+, npy+/- and npy-/- siblings (Figures 6E-6J). 319 
 320 
Fourth, we found that NPY regulates dbh expression in the LC. Overexpression of NPY decreased 321 
dbh mRNA level in the LC by 38% at 3 hours after heat shock in Tg(hsp:npy) larvae compared to 322 
WT siblings (P<0.05, two-tailed Student’s t test) (Figures 7A and 7D). This time point coincides 323 
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with the maximal effect of NPY overexpression on locomotor activity and sleep (Figures 1A and 324 
1C), suggesting that NPY overexpression-induced sleep may result from reduced dbh expression, 325 
and thus reduced NE levels. However, effects of NPY overexpression on behavior begin within 326 
the first hour after heat shock, and we only observed a trend of decreased dbh mRNA at 1 and 2 327 
hours after heat shock that did not reach statistical significance (Figure 7D). These observations 328 
suggest that reduced dbh expression may not be the primary cause of NPY overexpression-329 
induced sleep, but may rather be a secondary effect that supports and maintains NPY-induced 330 
sleep, perhaps resulting from decreased LC neuron activity. We also tested whether NPY 331 
overexpression affects the level of tyrosine hydroxylase (th), which acts upstream of dbh in the 332 
NE synthesis pathway, in LC neurons. We found that NPY overexpression did not significantly 333 
change th mRNA level in the LC at 1, 2 or 3 hours after heat shock (data not shown). Reduced 334 
dbh expression is not simply a consequence of increased sleep, as dbh mRNA level was 335 
unaffected following overexpression of prokineticin 2 (Prok2) (Figure 7E), which has sleep-336 
promoting effects similar to that of NPY overexpression [68]. Treatment of WT larvae with the 337 
sedative melatonin also did not affect dbh mRNA level (Figure 7E). The interaction between NPY 338 
and dbh appears to be specific, as NPY overexpression did not affect expression of other genes 339 
involved in promoting arousal, including the neuropeptides hypocretin (hcrt) [20, 48] or adenylate 340 
cyclase activating polypeptide 1a (adcyap1a) (Singh and Prober, unpublished) (Figures 7B, 7C 341 
and 7E). These results indicate that overexpression of NPY selectively decreases the level of dbh 342 
mRNA in the LC, presumably resulting in decreased NE levels and thus increased sleep. In 343 
support of this finding, we observed that dbh mRNA level was 33% higher in the LC of npy-/- 344 
larvae compared to their npy+/- and npy+/+ siblings during the day (Figures 7F and 7G) (P<0.05, 345 
one-way ANOVA, Holm-Sidak test). Moreover, we found that dbh mRNA level in the LC of WT 346 
larvae was 25% lower at night compared to the day (P<0.05, two-tailed Student’s t test) (Figures 347 
7H). This result demonstrates a correlation between the wake circadian phase of this diurnal 348 
species and the level of dbh mRNA in the LC, and suggests that changes in NE levels contribute 349 
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to the regulation of normal sleep/wake states. Taken together, these results are consistent with a 350 
model in which NPY promotes sleep by inhibiting NE signaling. 351 
 352 
DISCUSSION 353 
Using a genetic screening strategy to identify neuropeptides that regulate vertebrate sleep, here 354 
we show that NPY regulates sleep in the zebrafish, a diurnal vertebrate. Previous rodent studies 355 
using infusion of NPY peptide resulted in either increased [31-37] or decreased [40-42] sleep. In 356 
agreement with some of these studies, intravenous injection of NPY was shown to promote sleep 357 
in both young healthy men [38] and depressed human patients [39]. The opposite observed 358 
effects of NPY infusion may have resulted from different sites of injection or dosage, or the use 359 
of in vitro synthesized NPY peptide that may lack modifications present on endogenously 360 
produced peptide. These studies may also be confounded by extensive interactions between 361 
mechanisms that regulate sleep and other functions of NPY. Indeed, wake-promoting effects of 362 
injected NPY were associated with feeding-like behaviors in rats [40-42]. Central administration 363 
of NPY in rodents has also been shown to induce hypothermia [69] and to increase social 364 
interactions [70], which may affect sleep. Correlative studies have documented reduced NPY 365 
levels in patients with major depression who report sleep disturbances [71] and in Chinese 366 
patients with primary insomnia [72], consistent with a role for endogenous NPY in promoting 367 
sleep. Lower NPY levels are also found in individuals with post-traumatic stress disorder (PTSD) 368 
who have insomnia and fragmented sleep [73, 74]. Additional studies have implicated npy-369 
expressing neurons in mammalian sleep. For example, GABAergic cortical interneurons co-370 
expressing neuronal nitric oxide synthase (nnos) and npy express c-fos, a marker of neuronal 371 
activity, during sleep in rodents [75]. Furthermore, extracellular single-unit activity in the basal 372 
forebrain of anaesthetized rats showed increased firing of npy-expressing neurons during slow 373 
wave sleep [76]. 374 
 375 
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To address the role of endogenous NPY in sleep, we performed genetic gain- and loss-of-function 376 
studies using zebrafish larvae. These studies are performed before the onset of feeding, during 377 
which time larvae receive nutrients from the yolk sac [77], and before the onset of social 378 
interactions [78]. Furthermore, because zebrafish are poikilothermic, thermoregulation is unlikely 379 
to be a factor in studies of zebrafish sleep. Thus, zebrafish larvae allow the role of NPY in sleep 380 
to be addressed without complications of mammalian models. We found that overexpression of 381 
NPY suppresses locomotor activity and increases sleep during the day and night, whereas npy 382 
mutant zebrafish exhibit increased locomotor activity and decreased sleep during the day. 383 
Analysis of sleep architecture revealed that NPY overexpression results in shorter wake bouts, 384 
whereas npy mutants have longer wake bouts, suggesting that NPY regulates consolidation of 385 
the wake state. Consistent with this phenotype, we found that chemogenetic ablation of npy-386 
expressing neurons resulted in decreased sleep during the day, again due to longer wake bouts. 387 
The specificity of the loss-of-function phenotype to the day could be explained by the presence of 388 
redundant sleep-promoting systems at night, the primary sleep phase of zebrafish. Consistent 389 
with our observations, overexpression in Drosophila of neuropeptide F (NPF), a Drosophila 390 
homolog of NPY, or its receptor NPFR1, promotes sleep, although knockdown experiments did 391 
not show a sleep phenotype [79]. The Drosophila short neuropeptide F (sNPF), which is unrelated 392 
to NPF [80], is also thought to promote sleep [81] and has been referred to as an NPY ortholog, 393 
but is more likely an ortholog of vertebrate RFamide related peptides [80]. In C. elegans, 394 
locomotor quiescence during the developmentally regulated lethargus sleep state is abolished in 395 
mutants lacking the receptor npr-1 and reduced in mutants lacking the npr-1 ligands flp-18 and 396 
flp-21 [82]. npr-1 mutants also show increased responsiveness to oxygen and pheromones, 397 
resulting in altered foraging and accelerated locomotion [83-85]. While NPR-1 is structurally 398 
related to mammalian NPY receptors [86], FLP-18 and FLP-21 appear to be more similar to the 399 
RFamide family of peptides [80, 87].  Combined with our results, these studies establish NPY as 400 
a conserved sleep promoting neuropeptide in both vertebrates and invertebrates, and the 401 
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correlative human studies described above suggest that this function may be conserved in 402 
humans. 403 
 404 
npy is widely expressed in the mammalian brain, particularly in the hypothalamus, amygdala, LC 405 
and cerebral cortex [50, 51]. Similar to mammals, NPY is expressed in several discrete brain 406 
regions in zebrafish larvae. Because of this broad expression pattern, NPY could act via several 407 
known sleep/wake regulators. First, npy-expressing neurons innervate hcrt-expressing neurons 408 
in the hypothalamus, and application of NPY reduces spike frequency and hyperpolarizes hcrt 409 
neurons in mouse hypothalamic slices [88]. Second, a hypothalamic population of npy-expressing 410 
neurons project to the histaminergic tuberomammillary nucleus (TMN) in rodents [89]. Third, 411 
corticotropin releasing hormone (CRH) impairs sleep and enhances vigilance [90], and NPY 412 
enhances inhibitory synaptic transmission in crh-expressing neurons in amygdala brain slices 413 
[91]. Fourth, exogenous melatonin promotes sleep in diurnal vertebrates, including humans [92], 414 
and application of NPY to rat pineal explants increases melatonin production [93]. To determine 415 
whether any of these pathways underlie the sleep-promoting effects of NPY, we tested whether 416 
the NPY overexpression phenotype is blocked in zebrafish mutants in which these pathways are 417 
affected. We found that the NPY overexpression phenotype persisted in larvae lacking Hcrt 418 
signaling, histamine, CRH or melatonin using animals containing mutations in the hcrt receptor, 419 
hdc, crha, crhb or aanat2, respectively. We also found that NPY overexpression increased sleep 420 
in WT and melatonin-treated animals to a similar extent. These observations suggest that NPY 421 
does not affect sleep by modulating these pathways. 422 
 423 
In contrast to these negative results, we made several observations suggesting that NPY 424 
promotes sleep by inhibiting NE signaling. Both pharmacological and genetic studies in mammals 425 
and zebrafish have shown that NE promotes arousal [48, 64, 65]. We previously showed that both 426 
genetic and pharmacological inhibition of NE signaling increases sleep in zebrafish larvae [48]. 427 
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Here we found that although overexpression of NPY increases sleep in dbh+/- larvae and DMSO-428 
treated WT larvae, it does not enhance the increased sleep observed in dbh-/- larvae and 429 
prazosin-treated WT larvae. These results suggest that NPY overexpression promotes sleep by 430 
inhibiting NE signaling. Consistent with this possibility, we found that treatment with prazosin 431 
abolished the decreased sleep observed in npy mutants, suggesting that elevated NE signaling 432 
underlies this phenotype. In support of these functional interactions, we found that NPY 433 
overexpression decreases the level of dbh mRNA in the LC, the primary source of NE in the brain 434 
[65], and thus likely reduces NE levels. We observed a trend of reduced dbh mRNA levels at 1 435 
and 2 hours after induction of NPY overexpression that did not reach statistical significance, and 436 
a significant reduction at 3 hours post-heat shock. These observations suggest that reduced dbh 437 
expression may not be the primary cause of NPY overexpression-induced sleep, but rather may 438 
be a secondary effect that supports and maintains NPY-induced sleep, perhaps resulting from 439 
decreased LC neuron activity. Consistent with this possibility, in vitro synthesized NPY can inhibit 440 
LC neurons in rodent brain slices [94]. However, we observed the maximal effect of NPY 441 
overexpression on locomotor activity and sleep at ~3 hours after heat shock, coinciding with a 442 
significant reduction in dbh mRNA level in the LC, suggesting that NPY may directly promote 443 
sleep by decreasing dbh expression, and thus NE production, in the LC. Moreover, we found that 444 
npy mutants had higher dbh mRNA levels in the LC compared to sibling controls, presumably 445 
resulting in increased NE levels and increased wakefulness. It was recently shown that dbh levels 446 
in whole zebrafish larvae undergo a circadian oscillation [95]. Consistent with this observation, 447 
we found that the level of dbh mRNA in the LC is lower at night compared to the day, suggesting 448 
that NE levels may contribute to the diurnal sleep/wake cycle. 449 
 450 
Consistent with an interaction between NPY and the LC, we identified a small population of npy-451 
expressing neurons that is adjacent to, and appears to innervate, the LC. This observation 452 
contrasts with mammals, where npy and dbh are co-expressed in LC neurons [96, 97]. We were 453 
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unable to detect expression of NPY receptors in LC neurons, suggesting that NPY may indirectly 454 
affect NE signaling. However, expression of GPCRs, the protein class of NPY receptors, is 455 
notoriously difficult to detect, and we thus cannot rule out the possibility that a NPY receptor is 456 
expressed in LC neurons. We did observe expression of npyr1 and npyr2l in cells near the LC, 457 
suggesting the possibility of local indirect interactions between NPY neurons and the LC. Thus, 458 
while the anatomic interaction between the NPY and NE systems appears to differ in zebrafish 459 
and mammals, the functional relationship between the systems may be conserved. Taken 460 
together, these observations suggest that NPY could regulate sleep by directly affecting the firing 461 
of LC neurons and/or the level of NE. Alternately, the relevant site of action for the interaction 462 
between NPY and NE in sleep may lie in a network of neurons near the LC or elsewhere in the 463 
brain. 464 
 465 
In both mammals and zebrafish, NE signaling plays a key role in mediating the wake-promoting 466 
functions of Hcrt signaling and hcrt-expressing neurons [47, 48]. Here we provide evidence that 467 
NE signaling mediates the sedating effect of NPY, suggesting a central role for the NE system in 468 
neuropeptidergic regulation of sleep/wake states. Interestingly, while Hcrt and NPY have opposite 469 
effects on sleep via NE signaling, both neuropeptides promote feeding via neuronal substrates in 470 
the hypothalamus [30, 98], suggesting a segregation of neuronal circuits that mediate the effects 471 
of these neuropeptides on sleep and feeding. While an interaction between NPY and the LC has 472 
been shown to control stress responses in rodents [99], to our knowledge this is the first 473 
demonstration of an interaction between NPY and the NE system in the context of sleep. 474 
 475 
Recently the therapeutic potential of NPY has been demonstrated due to its ability to promote 476 
recovery after traumatic experiences for individuals with PTSD. Cerebrospinal fluid levels of NPY 477 
are reduced in individuals suffering from PTSD who have sleep disturbances [74]. Interestingly, 478 
treatment with prazosin substantially reduces nightmares and improves sleep in these patients 479 
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[74]. Since we found that NPY overexpression reduces the level of dbh mRNA, and presumably 480 
NE, the lower level of NPY in PTSD might result in increased NE levels, thereby disrupting sleep. 481 
Moreover, npy mutant mice exhibit anxiety-like symptoms that could result from a hyperactive LC 482 
[44, 100], suggesting that comorbidity of anxiety and sleep disturbances could result from this 483 
interaction. 484 
 485 
In summary, our results identify NPY as a regulator of sleep/wake behaviors in the zebrafish and 486 
suggest that NPY promotes sleep by inhibiting NE signaling. These results highlight a central role 487 
for NE signaling in regulating sleep, and suggest that modulation of NPY signaling may be a 488 
useful therapeutic approach for sleep disorders. 489 
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Contact for Reagent and Resource Sharing 506 
Further information and requests for reagents may be directed to, and will be fulfilled by, the Lead 507 
Contact David A. Prober (dprober@caltech.edu). 508 
 509 
Experimental Model and Subject Details 510 
Zebrafish experiments and husbandry followed standard protocols [101] in accordance with 511 
Caltech Institutional Animal Care and Use Committee guidelines. Larval zebrafish were studied 512 
before the onset of sexual differentiation and all behavioral experiments were performed using 513 
siblings with the same genetic background, differing only in the presence of a transgene, mutation 514 
of a specific gene, or treatment with drugs and appropriate vehicle controls. The age of animals 515 
used in each experiment is described in the manuscript, in each figure legend, and/or in the STAR 516 
Methods. 517 
 518 
Transgenic and mutant zebrafish 519 
Tg(hsp:npy) ct853Tg. Full-length zebrafish npy cDNA was isolated using 5’ and 3’ RACE 520 
(FirstChoice RLM-RACE, AM1700, Thermo Fisher Scientific) and the open reading frame was 521 
cloned downstream of the zebrafish hsp70c promoter [20] in a vector containing flanking I-SceI 522 
endonuclease recognition sites.  The same zebrafish npy gene was cloned in a previous study 523 
[102], but the gene isolated in our study contains an arginine residue located C-terminal to the 524 
mature peptide domain that was reported as an alanine residue in the previous study [102]. The 525 
sequence reported in our study is the same as that reported by the zebrafish genome sequencing 526 
project (www.ensembl.org/Danio_rerio). The alanine residue described in the previous report 527 
[102] is therefore likely either a sequencing error or a polymorphism in the fish strain used.  Stable 528 
transgenic lines were generated by injecting plasmids with I-SceI (R0694, New England Biolabs 529 
Inc.) into zebrafish embryos at the one-cell stage. Transgenic founders were identified by 530 
outcrossing potential founders, heat shocking progeny at 5 dpf, fixing animals 30 minutes after 531 
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heat shock and performing ISH using an npy-specific probe. Tg(hsp:npy) fish were genotyped 532 
using the primers 5’-CCGCCACCATGAATCCA-3’ and 5’-GGTTTGTCCAAACTCATCAATGT-3’, 533 
which generate a 370 bp band. We generated two independent Tg(hsp:npy) stable transgenic 534 
lines that produced similar phenotypes, but all data shown in the paper are from the line that 535 
produced stronger phenotypes. 536 
 537 
npy mutant ct811. npy mutant zebrafish were generated using the zinc finger nuclease method 538 
[56]. The mutant contains a 17 bp deletion (AGCCCGACAACCCGGGA) after nucleotide 94 of 539 
the open reading frame, resulting in a translational frame shift beginning at the fourth amino acid 540 
of the mature peptide domain. Mutant animals were genotyped using the primers 5’-541 
ATAAATTGCGCATCAGCACA-3’ and 5’-TGAGGAAGAATTTGAGACTACGC-3’, which produce 542 
a 281 or 264 bp band for the WT or mutant allele, respectively. npy heterozygous mutants were 543 
outcrossed to the parental TLAB strain for four generations before use in behavioral experiments. 544 
Homozygous npy mutants are viable, fertile, lack obvious developmental defects and are 545 
morphologically indistinguishable from WT animals. 546 
 547 
Tg(npy:kalta4) ct852Tg. We used bacterial artificial chromosome (BAC) recombineering [59] to 548 
insert an optimized version of the transcriptional activator Gal4 (KalTA4) [59] at the npy start 549 
codon of a BAC (zK50N10SP6; HUKGB735N1050Q, Source BioScience)) containing 288 kb of 550 
genomic sequence, including 145 kb upstream and 143 kb downstream of the npy gene. Primers 551 
of 70 nucleotides (pIndigoBAC_HA1_iTol2_F and pIndigoBAC_HA1_iTol2_R, Table S3) were 552 
used to amplify the long terminal repeats of the medaka Tol2 transposon to enable single-copy 553 
integration of the BAC into the zebrafish genome, using the plasmid pIndigoBAC-536 [59] as 554 
template. npy-specific primers were designed that contain 50 nucleotide homology arms around 555 
the npy start codon (positions -53 to -4 and +4 to +53) with ~20 nucleotide ends (Homology arm 556 
F and Homology arm R, Table S3 to amplify a KalTA4_kanamycin cassette from the plasmid 557 
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pCS2+_kalta4_kanR [59]. These plasmids were a kind gift from Dr. Stefan Schulte-Merker. The 558 
modified BAC was purified using the Nucleobond BAC 100 kit (740579, Macherey-Nagel) and 559 
injected into zebrafish embryos at the one- or two-cell stage at a concentration of 50 ng/µL, along 560 
with tol2 transposase mRNA at a concentration of 50 ng/µL. Transgenic lines were identified by 561 
mating potential founders to WT TLAB fish, and progeny were genotyped using the primers 5’-562 
CGCTATCATTTATAGATTTTTGCAC-3’ and 5’-AGTAGCGACACTCCCAGTTG-3’, which 563 
produce a 220 bp band in transgenic animals. Transgenic founders were crossed to the 564 
Tg(uas:nfsb-mcherry) line [60] and the strongest line was identified by fluorescence microscopy. 565 
 566 
Other transgenic and mutant lines. The Tg(dbh:EGFP) transgenic line [67], dbh mutant [48], hcrtr 567 
mutant [19], hdc mutant [62], and aanat2 mutant [63] have been previously described. The crha 568 
and crhb mutants are unpublished (Singh and Prober unpublished). 569 
 570 
Method Details 571 
Locomotor activity assay. At 4 dpf, individual larvae were placed into each well of a 96-well plate 572 
(7701-1651, GE Healthcare Life Sciences) containing 650 μL of E3 embryo medium (5 mM NaCl, 573 
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7.4). Plates were sealed with an optical 574 
adhesive film (4311971, Applied Biosystems) to prevent evaporation, except in experiments 575 
where drugs were added. The sealing process introduces air bubbles in some wells, which are 576 
excluded from analysis. In experiments using transgenic animals, larvae were blindly assigned a 577 
position in the plate, and were genotyped after the behavioral experiment was completed. 578 
Locomotor activity was monitored using an automated videotracking system (Viewpoint Life 579 
Sciences) with a Dinion one-third inch monochrome camera (Dragonfly 2, Point Grey) fitted with 580 
a fixed-angle megapixel lens (M5018-MP, Computar) and infrared filter. For heat shock-induced 581 
overexpression experiments, larvae were heat shocked at 37°C for 1 hour starting at either 3 p.m. 582 
or 10 p.m. at 5 dpf. The movement of each larva was captured at 15 Hz and recorded using the 583 
 24 
quantization mode in 1-minute time bins. The 96-well plate and camera were housed inside a 584 
custom-modified Zebrabox (Viewpoint Life Sciences) that was continuously illuminated with 585 
infrared LEDs, and illuminated with white LEDs from 9 a.m. to 11 p.m., except as noted in constant 586 
light or constant dark experiments. The 96-well plate was housed in a chamber filled with 587 
recirculating water to maintain a constant temperature of 28.5°C. The parameters used for 588 
detection were: detection threshold, 15; burst, 29; freeze, 3, which were determined empirically. 589 
Data were processed using custom PERL and Matlab (The Mathworks, Inc.) scripts, and 590 
statistical tests were performed using Prism 6 (GraphPad). 591 
 592 
A movement was defined as a pixel displacement between adjacent video frames preceded and 593 
followed by a period of inactivity of at least 67 ms (the limit of temporal resolution). Any one-594 
minute period with no movement was defined as one minute of sleep based on arousal threshold 595 
changes [20]. A sleep bout was defined as a continuous string of sleep minutes. Average activity 596 
was defined as the average amount of activity in seconds/hour, including sleep bouts. 597 
 598 
Arousal threshold assay. The arousal threshold assay was performed as described [48]. Animals 599 
were heat shocked at 5 dpf from 12 p.m. to 1 p.m, and taps of 14 different intensities were applied 600 
in a random order from 3 p.m. to 10 p.m. Thirty trials were performed at each stimulus intensity, 601 
with a 1-minute inter-trial interval. The background probability of movement was calculated by 602 
identifying for each genotype the fraction of larvae that moved 5 seconds prior to all stimuli 603 
delivered. This value was subtracted from the average response fraction value for each tap event. 604 
A response is defined as any movement that occurred within 1 second after a tap was delivered. 605 
Data was analyzed using Matlab (Mathworks, Inc.) and dose-response curves were constructed 606 
using the Variable Slope log(dose) response curve fitting module of Prism (Graphpad) and fitted 607 
using ordinary least squares. The effective tap power 50 (ETP50) was defined as the tapping 608 
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intensity at which 50% of the maximum number of responding larvae occurs, based on the fitted 609 
curve. 610 
 611 
Tapping experiments with a 5-minute inter-trial interval were performed using three tap intensities 612 
of 2.3, 3.0 and 4.0 arbitrary units to assess the response of awake and sleeping larvae to the 613 
stimuli. These stimulus intensities were chosen because they were lower than the ETP50 of 614 
animals of both genotypes. Animals were heat shocked at 5 dpf from 12 p.m. to 1 p.m., and thirty-615 
three trials were performed at each stimulus intensity in a random order from 3:00 p.m. to 10:30 616 
p.m. Behavioral responses were analyzed as described above. Three independent experiments 617 
for were performed for both 1-minute and 5-minute tapping assays, and one representative 618 
experiment for each is shown. 619 
 620 
In situ hybridization (ISH). Animals were fixed in 4% paraformaldehyde (PFA) in phosphate 621 
buffered saline (PBS) for 16 hours at room temperature. ISH was performed using digoxygenin 622 
(DIG) labeled antisense riboprobes (DIG RNA Labeling Kit, 11175025910, Sigma-Aldrich), 623 
followed by incubation with a sheep anti-digoxigenin-POD antibody (1:400; 11207733910, Sigma-624 
Aldrich), and developed using the TSA Plus Fluorescein and Cyanine 3 System (NEL753001KT, 625 
PerkinElmer). Double-fluorescent ISH was performed using DIG- and fluorescein-labeled 626 
riboprobes (Fluorescein RNA Labeling kit, 11685619910, Sigma-Aldrich), and the TSA Plus 627 
Fluorescein and Cyanine 3 System (NEL753001KT, PerkinElmer) using a previously described 628 
protocol [20]. Probes specific for npy, dbh, adcyap1a, kalta4, npyr1, npyr2, npyr2l, npyr4, npyr7, 629 
npyr8a and npyr8b were synthesized using standard protocols [103]. The npy probe was 630 
transcribed using a PCR product amplified from a zebrafish cDNA library using the primers 631 
Forward: 5’-CCACAGAGCAAGAATTCCAA-3’ and Reverse: 5’- 632 
CAGTCATTATTGTTCTCCTTTGC-3’, and then serially amplified with the same Forward primer 633 
and the Reverse Primer with a T7 promoter sequence added: 5’-634 
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TAATACGACTCACTATAGGGCAGTCATTATTGTTCTCCTTTGC-3’. The kalta4 probe was 635 
transcribed using the plasmid pCS2+_kalta4_kanR [59] as a template after linearization with 636 
BamH1 and using T7 RNA polymerase (10881767001, Sigma-Aldrich). A probe specific for dbh 637 
has been previously described [104]. Probes specific for adcyap1a, npyr1, npyr2, npyr2l, npyr4, 638 
npyr7, npyr8a and npyr8b were generated as described for the npy-specific probe using the 639 
primers listed in Table S3. 640 
 641 
Immunohistochemistry (IHC). Samples were fixed in 4% PFA in PBS overnight at 4°C and then 642 
washed with 0.25% Triton X-100/PBS (PBTx). Brains were manually dissected and blocked for at 643 
least 1 hour in 2% goat serum/2% dimethyl sulfoxide (DMSO)/PBTx at room temperature or 644 
overnight at 4°C. Primary antibody incubations were performed in blocking solution overnight at 645 
4°C using chicken anti-GFP (1:400, GFP-1020, Aves Labs, Inc.) and rabbit anti-DsRed (1:100, 646 
632496, Clontech Laboratories, Inc.). Secondary antibody incubations were performed in blocking 647 
solution overnight at 4°C using Alexa Fluor 488 goat anti-chicken (1:500, A-11039, Thermo Fisher 648 
Scientific) and Alexa Fluor 568 goat anti-rabbit (1:500, A-11011, Thermo Fisher Scientific) 649 
antibodies. Samples were mounted in 50% glycerol/PBS and imaged using a Zeiss LSM 780 650 
confocal microscope with a 25x 0.8 NA water immersion objective (LD LCI Plan-Apochromat 651 
25x/0.8 1mm Corr DIC M27). Images were processed using Fiji [105]. 652 
 653 
Z-brain registration. WT larvae were fixed at 6 dpf and ISH was performed using an npy-specific 654 
probe on dissected brains as described above, followed by IHC using mouse anti-t-ERK primary 655 
antibody (1:500, 4696, Cell Signaling Technology) and Alexa Fluor 488 goat anti-mouse 656 
secondary antibody (1:500, A32723, Thermo Fisher Scientific). Imaging was performed using a 657 
Zeiss 780 confocal microscope, using a 20x 1.0 NA water dipping objective (W Plan-Apochromat 658 
20x/1.0 DIC CG=0.17 M27 75mm) and imaged at ~0.8/0.8/2 µm voxel size (x/y/z) using the Zeiss 659 
tiling function and the pairwise stitching function of Fiji [105]. Non-rigid image registration was 660 
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performed using the Computational Morphometry Toolkit (CMTK, 661 
http://www.nitrc.org/projects/cmtk/) as previously described [52]. t-ERK staining was used to 662 
register to the t-ERK reference brain [52], which was then used to align npy ISH labeling. 663 
Registered brains were analyzed using the Z-Brain browser (MATLAB) [52] to identify anatomical 664 
regions expressing npy. Using Fiji, the registered brain showing npy expression was merged to 665 
the database ‘Anti-tERK_6dpf_MeanImageOf193Fish’ from ‘AnatomyLabel 666 
DatabaseDownsampled’ from the Z-Brain Downloads [52] to show the expression of npy relative 667 
to t-ERK in the reference 6 dpf zebrafish larva. The combined stack was converted into a video 668 
and processed in Windows Movie Maker to add anatomical labels. 669 
 670 
Image processing in Imaris and Fiji. Surface rendering to reconstruct projections of npy- and dbh-671 
expressing neurons was performed using Imaris 9 (Bitplane). To perform surface rendering, we 672 
used the Volume function followed by the Normal Shading mode to add a depth effect to the 2-673 
dimensional z-stack imaged using a 63x 1.4 NA oil immersion objective (Plan-Apochromat 63x/1.4 674 
oil DIC M27), and then displayed the image in the 3-dimensional isometric view. We then used 675 
the Interactive Software Histogram to select a threshold that included as much of the neuronal 676 
projections as possible while excluding any background. Areas of overlap between projections 677 
from npy- and dbh-expressing neurons were magnified 4-fold and saved as TIFF images. 678 
 679 
To identify the sources of overlapping projections, a 63x z-stack of npy-expressing and dbh-680 
expressing neurons was converted to an 8-bit stack. Projections from a single npy-expressing 681 
neuron and a single dbh-expressing neuron were manually traced using the Simple Neurite Tracer 682 
plugin in Fiji. Tracings were then filled-in using the same plugin, with an exemplar npy-expressing 683 
neuron labeled magenta and an exemplar dbh-expressing neuron labeled green, and saved as 684 
individual z-stacks. These z-stacks were then merged with the original z-stack to so that the traced 685 
npy-expressing and dbh-expressing neurons were overlaid on the original images. As a result, 686 
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the traced npy-expressing neuron appears magenta and the traced dbh-expressing neuron 687 
appears yellow. This merged image stack is shown in Video S2. 688 
 689 
TUNEL staining. Tg(npy:kalta4);Tg(uas:nfsb-mcherry) larvae were treated with DMSO or 10 mM 690 
MTZ for 18 hours starting at 3 dpf, and then were fixed in 4% PFA in PBS for 16 hours at 4°C, 691 
and subjected to a TUNEL Assay (In Situ Cell Death Detection Kit, 11684795910, Sigma-Aldrich) 692 
according to the manufacturer’s instructions. 693 
 694 
Analysis and quantification of dbh expression using ISH. dbh ISH was performed by incubating 695 
fixed 5 dpf brains with a DIG-labeled dbh antisense riboprobe, followed by a sheep anti-696 
digoxigenin-POD antibody (1:400; 11207733910, Sigma-Aldrich), and developed using the TSA 697 
Plus Cyanine 3 System (NEL753001KT, PerkinElmer). Samples were developed using the 698 
cyanine 3 substrate at 1:300 for 5 minutes to avoid saturation. Brains were imaged using a Zeiss 699 
LSM 780 confocal microscope using a 561 nm laser and a 25x 0.8 NA water immersion objective 700 
(LD LCI Plan-Apochromat 25x/0.8 1mm Corr DIC M27). To quantify dbh expression in 701 
Tg(hsp:npy) animals, larvae were heat shocked from 3 p.m. to 4 p.m. and samples were collected 702 
at the indicated times after heat shock. To quantify dbh expression in npy mutants, samples were 703 
collected at 4 p.m. Both experiments used siblings whose brains were processed for ISH in the 704 
same tube, imaged, quantified and then genotyped by PCR. To compare dbh expression levels 705 
during the day and night, day samples were collected at 4 p.m. and night samples were collected 706 
at 2 a.m. After fixation, a small nick was made in the forebrain of night samples to enable their 707 
identification at the end of the experiment. Day and night samples were then placed together in 708 
the same tube, processed for ISH, imaged and then quantified. Three independent experiments 709 
were performed and images of representative samples are shown.  For quantification of dbh 710 
mRNA level, confocal z-stacks were obtained as described above. Using Fiji [105], each z-stack 711 
was converted into a maximum intensity projection, converted into 8-bit grayscale, and 712 
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thresholded to select only the fluorescent ISH signal. This function was applied to all images in 713 
an experiment to determine a threshold level that was optimal for most images, and this threshold 714 
was then used for all images in an experiment. The Analyze-Set Measurements function was 715 
used to select Integrated Density as the measurement parameter and Limit to Threshold was 716 
selected to measure only the thresholded region. Fluorescent intensity was then measured by the 717 
Analyze-Measure function. 718 
 719 
Statistical Analysis 720 
All line graphs show a 1 hour forward moving average plotted in 10 minute bins, except Figures 721 
S1B and S1E, which show data plotted in 10 minute bins. Line and bar graphs show mean ± 722 
standard error of the mean (SEM). In all statistical tests, the significance threshold was set to 723 
P<0.05. Parametric statistical tests were used because the data followed an approximately 724 
normal distribution. For behavioral experiments that compared two genotypes, statistical 725 
significance was assessed using a two-tailed Student’s t test. For npy mutant experiments, which 726 
compared animals of three different genotypes, one-way ANOVA followed by the Holm-Sidak 727 
correction for multiple comparisons was performed to test for significant pair-wise comparisons 728 
among all genotypes. The Holm-Sidak test was used to focus on significance but not confidence 729 
intervals. For experiments in which NPY was overexpressed in various mutant backgrounds or in 730 
which NPY overexpression was combined with drug treatments, statistical significance was 731 
assessed using two-way ANOVA followed by the Holm-Sidak correction for multiple comparisons. 732 
For experiments in which npy mutants were treated with drugs, statistical significance was 733 
assessed using two-way ANOVA followed by Holm-Sidak correction for multiple comparisons. 734 
For quantification of ISH data, statistical significance was assessed using a two-tailed Student’s 735 
t test for experiments that compared two samples, and one-way ANOVA followed by the Holm-736 
Sidak correction for multiple comparisons for experiments that compared three or more samples. 737 
Behavioral data was processed using Matlab (MathWorks), graphs were generated using Excel 738 
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(Microsoft), and statistical analyses were performed using Prism 6 (Graphpad). The number of 739 
animals and statistical test used are stated in each figure or figure legend. 740 
 741 
Data and Software Availability 742 
Custom PERL and MATLAB code used for zebrafish behavioral analysis is available upon 743 
request.  744 
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FIGURE LEGENDS 1035 
Figure 1. Overexpression of zebrafish NPY increases sleep and arousal threshold. (A-G) 1036 
Overexpression of zebrafish NPY following a heat shock at 3 p.m. results in decreased locomotor 1037 
activity (A,B) and increased sleep (C,D). Yellow bars in line graphs indicate time of heat shock 1038 
(HS). NPY overexpression increased the number of sleep bouts (E) and decreased the length of 1039 
both sleep bouts (F) and wake bouts (G). Pre-HS and Post-HS quantify data for day 5 before and 1040 
after heat shock, respectively. Mean ± SEM from 4 pooled experiments is shown. (H) 1041 
Representative stimulus-response curve for Tg(hsp:npy) animals compared to WT siblings 1042 
following heat shock at 12 p.m. Each data point represents mean ± SEM. Dashed lines mark the 1043 
ETP50 value for each genotype. Tg(hsp:npy) animals had an ETP50 value of 24.2 vs. 8.2 for WT 1044 
siblings (293% increase, P< 0.05 by extra sum-of-squares F test). (I,J) Overexpression of NPY 1045 
reduces the response of Tg(hsp:npy) animals to the stimulus compared to WT siblings during 1046 
both awake and sleep states. Stimulus intensities of 2.3, 3.0 and 4.0 arbitrary units (a.u.) were 1047 
tested. A dose-dependent response is observed for WT animals but not for their Tg(hsp:npy) 1048 
siblings. Bar graphs show mean ± SEM. n=number of animals. *P<0.05; **P<0.01; ***P<0.001; 1049 
****P<0.0001 by two-tailed Student’s t test. See also Figures S1 and S2. 1050 
 1051 
Figure 2. Loss of npy reduces daytime sleep. (A) Amino acid sequences of WT and mutant 1052 
zebrafish NPY proteins. The mature peptide is indicated with a red box. The altered amino acids 1053 
following the frameshift in the mutant are shaded grey. (B-M) npy-/- animals were more active 1054 
(B,C), and slept less (E,F), than their npy+/+ and npy+/- siblings during the day. During the day, 1055 
npy-/- animals had fewer sleep bouts (H), and longer wake bouts (L) than their npy+/+ and npy+/- 1056 
siblings. Mean ± SEM from 7 pooled experiments is shown. n=number of animals. **P<0.01; 1057 
***P<0.001; ****P<0.0001 by one-way ANOVA with Holm-Sidak post hoc test. 1058 
 1059 
 44 
Figure 3. Entrained npy mutants sleep less in constant light. Larvae were entrained in 14:10 1060 
hour LD cycles for the first 4 days and nights of development, then behaviorally monitored for 24 1061 
hours in LD and then for 48 hours in LL. npy-/- animals were more active (A-C) and slept less (D-1062 
F) than their npy+/- and npy+/+ siblings during subjective day and night. npy-/- animals had fewer 1063 
(G,H) and shorter (I,J) sleep bouts, and longer wake bouts (K,L) than their npy+/- and npy+/+ 1064 
siblings. Mean ± SEM from 3 pooled experiments is shown. n=number of animals. *P<0.05; 1065 
**P<0.01; ***P<0.001; ****P<0.0001 by one-way ANOVA with Holm-Sidak post hoc test. See also 1066 
Figure S3. 1067 
 1068 
Figure 4. Loss of npy-expressing neurons reduces daytime sleep. (A) Ventral views of brains 1069 
from 5 dpf Tg(npy:kalta4);Tg(uas:nfsb-mcherry) animals stained with anti-DsRed antibody 1070 
following treatment with either DMSO (A) or 10 mM MTZ (A’), showing nearly complete loss of 1071 
mCherry labeling after MTZ treatment. (B) Mean ± SEM mCherry fluorescence intensity for 1072 
Tg(npy:kalta4);Tg(uas:nfsb-mcherry) animals treated with DMSO (n=4) or MTZ (n=4). (C-N) 1073 
Tg(npy:kalta4);Tg(uas:nfsb-mcherry) animals treated with MTZ were more active (C,D) and slept 1074 
less (F,G) than their identically treated Tg(npy:kalta4) siblings during the day. This phenotype was 1075 
due to fewer sleep bouts (I) and longer wake bouts (M). Mean ± SEM from 3 pooled experiments 1076 
is shown (C-N). n=number of animals. *P<0.05; **P<0.01; ****P<0.0001 by two-tailed Student’s t 1077 
test. See also Figures S4, S5 and Table S1. 1078 
 1079 
Figure 5. Evidence for anatomical interaction between hindbrain NPY neurons and the 1080 
locus coeruleus. (A) Double FISH using probes specific for npy and dbh show their close 1081 
proximity in the LC. Boxed region in (A”) is shown at higher magnification in a 50 µm thick 1082 
maximum intensity projection in (B). (C) Tg(npy:kalta4);Tg(uas:nfsb-mcherry);Tg(dbh:EGFP) 1083 
brains labeled using anti-DsRed and anti-EGFP antibodies. Boxed region in (C”) is shown at 1084 
higher magnification (25x) in (D) and (63x) in (D’). Maximum intensity projections 40 µm and 63 1085 
 45 
µm thick are shown in (D) and (D’), respectively. (E) Imaris surface renderings of the boxed region 1086 
in (D’). Boxed regions are shown at higher magnification in (F-H). White asterisks show close 1087 
proximity of projections from NPY and LC neurons. (I-J) ISH using npyr1- and npyr2l-specific 1088 
probes and immunostaining using an anti-EGFP antibody in Tg(dbh:EGFP) brains reveal close 1089 
proximity of npyr1 (I) and npyr2l (J) to dbh-expressing LC neurons. (I’) and (J’) show orthogonal 1090 
views of the 24 µm and 25 µm thick maximum intensity projections shown in (I) and (J), 1091 
respectively. a, anterior; p, posterior. All samples are 5 dpf brains. Scale bar: (A-C) 50 µm, (B,D) 1092 
10 µm, (D’) 7.5 µm, (E) 2.0 µm  and (F-H) 0.5 µm. 1093 
 1094 
Figure 6. Functional evidence that NPY promotes sleep by inhibiting noradrenergic 1095 
signaling. (A-D) The sedating effects of NPY overexpression and loss of NE signaling are not 1096 
additive. Tg(hsp:npy);dbh-/- and dbh-/- animals were less active (A,B) and slept more (C,D) than 1097 
their dbh+/- siblings during the day before and after heat shock. Tg(hsp:npy);dbh+/- animals were 1098 
less active and slept more than their dbh+/- siblings during the day after heat shock. NPY 1099 
overexpression in Tg(hsp:npy);dbh-/- animals did not further decrease locomotor activity or 1100 
increase sleep compared to their dbh-/- siblings. Yellow bars in line graphs indicate time of heat 1101 
shock (HS). Pre-HS and Post-HS quantify data before and after heat shock. (E-J) Treatment with 1102 
prazosin abolishes the npy mutant activity and sleep phenotypes. npy+/+, npy+/- and npy-/- 1103 
siblings were treated with either DMSO or prazosin. DMSO-treated npy-/- larvae were more active 1104 
(E,F) and slept less (H,I) than their DMSO-treated npy+/- and npy+/+ siblings during the day. 1105 
Prazosin treatment decreased activity (E,F) and increased sleep (H,I) to a similar extent for npy-1106 
/-, npy+/- and npy+/+ siblings. Arrows indicate behavioral artifacts due to addition of water to each 1107 
well. Mean ± SEM for 2 (A-D) or 4 (E-J) pooled experiments is shown. n=number of animals. 1108 
n.s.=not significant, *P<0.05; **P<0.01; ****P<0.0001 by two-way ANOVA with Holm-Sidak post 1109 
hoc test. See also Table S2 and Figures S6 and S7. 1110 
 1111 
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Figure 7. NPY signaling affects dbh mRNA level in the LC. (A) ISH showing dbh expression 1112 
in the LC (boxed) and medulla oblongata. dbh mRNA levels were lower in Tg(hsp:npy) animals 1113 
(A”) compared to their WT siblings (A’) after heat shock. ISH using probes specific for adcyap1a 1114 
(B) and hcrt (C). Boxed regions in (A-C) are quantified in (D,E). (D) dbh mRNA level in the LC is 1115 
decreased in Tg(hsp:npy) animals compared to their WT siblings at 3 hours post HS, but there is 1116 
no significant difference at 1, 2, or 7 hours post HS. (E) Overexpression of Prok2 or treatment 1117 
with 20 µM melatonin did not affect dbh mRNA level. Overexpression of NPY did not affect 1118 
adcyap1a or hcrt mRNA level. (F-F’) dbh mRNA level in the LC was higher in npy-/- animals (F’) 1119 
compared to their npy+/+ siblings (F). (G) Quantification of dbh mRNA level in the LC of npy-/- 1120 
larvae and their sibling controls. (H) dbh mRNA levels in the LC of WT larvae were lower at night 1121 
compared to the day. Mean ± SEM integrated fluorescence pixel intensity from 8-12 brains for 1122 
each condition is shown. *P<0.05 by two-tailed Student’s t test (D,H) or by one-way ANOVA with 1123 
Holm-Sidak post hoc test (G). a, anterior; p, posterior. All samples are 5 dpf brains. Scale bar: 1124 
(A,B,C) 100 µm; (A’,A’’,F,F’) 10 µm. 1125 
 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Chicken anti-GFP Aves Labs, Inc. Cat# GFP-1020; 
RRID: AB_10000240 
Rabbit anti-DsRed Clontech Laboratories, 
Inc. 
Cat# 632496;  
RRID: AB_10013483 
Mouse anti-Erk1/2 (t-ERK) Cell Signaling 
Technology 
Cat# 4696;  
RRID: AB_390780 
Goat anti-chicken IgG secondary antibody, Alexa 488 
conjugate 
Thermo Fisher 
Scientific 
Cat# A-11039;  
RRID: 2534096 
Goat anti-rabbit IgG secondary antibody, Alexa 568 
conjugate 
Thermo Fisher 
Scientific 
Cat# A-11011;  
RRID: AB_143157 
Goat anti-mouse IgG secondary antibody, Alexa 488 
conjugate 
Thermo Fisher 
Scientific 
Cat# A32723;  
RRID: AB_2633275 
Sheep anti-Digoxigenin-POD, Fab fragments  Sigma-Aldrich Cat# 11207733910; 
RRID: AB_514500 
Sheep anti-Fluorescein-POD, Fab fragments  Sigma-Aldrich Cat# 11426346910; 
RRID: AB_840257 
Chemicals, Peptides, and Recombinant Proteins 
16% paraformaldehyde Electron Microscopy 
Sciences 
Cat# 15710 
Normal goat serum Thermo Fisher 
Scientific 
Cat# 31873 
Prazosin hydrochloride Sigma-Aldrich Cat# P7791 
Melatonin Sigma-Aldrich Cat# M5250 
Metronidazole Sigma-Aldrich Cat# 46461 
Dimethyl sulfoxide Macron Fine 
Chemicals 
Cat# 4948 
T7 RNA polymerase Sigma-Aldrich Cat# 10881767001 
Blocking reagent Sigma-Aldrich Cat# 11096176001 
Critical Commercial Assays 
DIG RNA Labeling Kit Sigma-Aldrich Cat# 11175025910 
Fluorescein RNA Labeling Kit Sigma-Aldrich Cat# 11685619910 
FirstChoice RLM-RACE Thermo Fisher 
Scientific 
Cat# AM1700 
TSA Plus Cyanine 3 and Fluorescein System PerkinElmer Cat# NEL753001KT 
NucleoBond BAC 100 purification kit Macherey-Nagel Cat# 740579 
In Situ Cell Death Detection Kit, Fluorescein Sigma-Aldrich Cat# 11684795910 
Experimental Models: Organisms/Strains 
Zebrafish: Tg(hsp:npy) ct853Tg This paper RRID: ZDB-ALT-
171002-3 
Zebrafish: npy ct811 mutant  [56] RRID: ZDB-ALT-
131125-18 
Zebrafish: Tg(npy:kalta4) ct852Tg This paper RRID: ZDB-ALT-
170927-8 
Zebrafish: Tg(uas:nfsb-mcherry) ct264Tg  [60] RRID: ZDB-ALT-
070316-1 
Zebrafish: Tg(dbh:EGFP) ct821Tg  [67] RRID: ZDB-ALT-
150605-3 
Key Resource Table
Zebrafish: aanat2 ct801 mutant  [63] RRID: ZDB-ALT-
131122-2 
Zebrafish: hcrtr hu2098 mutant  [19] RRID: ZDB-ALT-
070427-14 
Zebrafish: hdc ct836 mutant  [62] RRID: ZDB-ALT-
170509-2 
Zebrafish: crha ct861 mutant This paper RRID: ZDB-ALT- 
171009-1 
Zebrafish: crhb ct862 mutant This paper RRID: ZDB-ALT-
171009-2 
Oligonucleotides 
Primers for genotyping, see Table S3 This paper N/A 
Primers for riboprobe synthesis, see Table S3 This paper N/A 
Primers for BAC transgenesis, see Table S3 This paper N/A 
Recombinant DNA 
Tg(hsp:npy) This paper N/A 
Tg(npy:kalta4) BAC This paper N/A 
pIndigoBAC  [59] N/A 
pCS2+_kalta4_kanR  [59] N/A 
Software and Algorithms 
Excel Microsoft https://products.office.
com/en-us/excel 
Fiji  [105] https://fiji.sc; RRID: 
SCR_002285 
GraphPad Prism6 GraphPad Software http://www.graphpad.c
om/; RRID: 
SCR_002798 
MATLAB MathWorks, Inc. https://www.mathwork
s.com/products/matlab 
Computational Morphometry Toolkit NITRC (CMTK, 
http://www.nitrc.org/pr
ojects/cmtk/) 
Imaris 9 Bitplane http://www.bitplane.co
m/imaris; RRID: 
SCR_007370 
Other 
96-well plate for behavioral experiments GE Healthcare Life 
Sciences 
Cat# 7701-1651 
MicroAmp Optical Adhesive Film Thermo Fisher 
Scientific 
Cat# 4311971 
Plasmid for hcrt riboprobe synthesis  [20] N/A 
Plasmid for dbh riboprobe synthesis  [48] N/A 
Plasmid for adcyap1a riboprobe synthesis This paper N/A 
Plasmid for npy riboprobe synthesis This paper N/A 
BAC containing zebrafish npy locus Source BioScience zK50N10SP6 
(HUKGB735N1050Q) 
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Figure S1. A genetic screen identifies a sleep-promoting role for NPY and 
zebrafish npy is widely expressed in the brain (Related to Figure 1 )
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Figure S2. NPY overexpression increases sleep at night and during subjective 
day in constant dark (Related to Figure 1)
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Figure S3. Loss of npy reduces daytime sleep before transition to constant 
light (Related to Figure 3)
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Figure S4. The npy:kalta4 and uas:nfsb-mcherry transgenes do not affect 
sleep/wake behaviors compared to WT siblings (Related to Figure 4)
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Figure S5. Specific expression of kalta4 in npy-expressing neurons and TUNEL labeling of 
apoptotic cells (Related to Figure 4)
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Figure S6. The sedating effects of NPY overexpression and inhibition of NE 
signaling are not additive (Related to Figure 6) 
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Table S1. Percentage of npy-expressing cells that express kalta4 in 
Tg(npy:kalta4) larvae (Related to Figure 4)
Symbol Brain region % kalta4-expressing 
neurons co-
expressing npy
% npy neurons co-
expressing kalta4
A Olfactory bulb 100.00 ± 0.00 91.67 ± 6.81
B Telencephalon 98.92 ± 1.07 95.10 ± 1.97
C Preoptic area 97.07 ± 1.61 88.71 ± 2.53
D Posterior tuberculum 98.72 ± 1.28 89.31 ± 3.31
E Intermediate lateral 
Hypothalamus
100.00 ± 0.00 94.44 ± 5.56
F Caudal medial 
Hypothalamus
100.00 ± 0.00 88.89 ± 11.12
G Pretectum 98.04 ± 1.96 83.06 ± 1.17
H Torus semicircularis 95.77 ± 2.41 88.34 ± 4.52
I Tectum 98.03 ± 0.98 89.09 ± 1.04
J Locus coeruleus 100.00 ± 0.00 88.89 ± 11.12
K Medial rhombomere 96.67 ± 3.33 82.22 ± 1.11
L Subpallium 92.86 ± 5.83 86.61 ± 0.72
TableS1
Table S2. Mutants and drugs tested for effects on NPY overexpression-induced 
sleep  (Related to Figure 6)
Mutant System Affected
histidine decarboxylase no histamine
hypocretin receptor no hypocretin signaling
corticotropin releasing hormone a no crha
corticotropin releasing hormone b no crhb
arylalkylamine N-acetyltransferase 2 no melatonin
TableS2
Genotyping Primers
Primer Name Primer Sequence
hsp:npy genotype F CCGCCACCATGAATCCA
hsp:npy genotype R GGTTTGTCCAAACTCATCAATGT
npy mutant genotype F ATAAATTGCGCATCAGCACA
npy mutant genotype 
R
TGAGGAAGAATTTGAGACTACGC
npy:kalta4 genotype F CGCTATCATTTATAGATTTTTGCAC
npy:kalta4 genotype R AGTAGCGACACTCCCAGTTG
Primers for Riboprobe Synthesis
Primer Name Primer Sequence
npy riboprobe F CCACAGAGCAAGAATTCCAA
npy riboprobe R CAGTCATTATTGTTCTCCTTTGC
adcyap1a riboprobe F ATGATTACGAGCAGCAAAACGACTC
adcyap1a riboprobe R TCACAAAGCCGGGAATTCAG
npyr1 riboprobe F CTGACCGACAGCAGTGTGTT
npyr1 riboprobe R CCGGTGGTGTAGGTGAGTTT
npyr2 riboprobe F CGCAATTTACACACGGTGAC
npyr2 riboprobe R TCCCTTACTGCCTCACTGCT
npyr2l riboprobe F GGCTTGTGTGGATGGATGTA
npyr2l riboprobe R TGTCGAGGTGGTAAACGATG
npyr4 riboprobe F GTCCTAGGGGTGTGCATGTC
npyr4 riboprobe R AATAGCAACAAGCTGGTGGTG
npyr7 riboprobe F AAGAGACCAGCCTGGGAAAT
npyr7 riboprobe R AAACTGCGAAGACCACGACT
npyr8a riboprobe F CCAGAAATCATGGGTGGAGT
npyr8a riboprobe R GCAAATGCAACCACAATCAC
npyr8b riboprobe F CGAAGCGTTATGCAAAGTGA
npyr8b riboprobe R TTGCTCAAGATGGAGCCTTT
Primers for BAC transgenesis
Primer Name Primer Sequence
Homology arm F AACAATAAATTGCGCATCAGCACAAACACGTTTGCTTTGTTTAATTGCAG
Homology arm R AAGAGAAACGCGCACGCTGCCCAGCTCATCCACATCTTCATGTTTGGAT
T
pIndigoBAC_HA1_iTol
2_F
TTCTCTGTTTTTGTCCGTGGAATGAACAATGGAAGTCCGAGCTCATCGC
TCCCTGCTCGAGCCGGGCCCAAGTG
pIndigoBAC_HA1_iTol
2_R
AGCCCCGACACCCGCCAACACCCGCTGACGCGAACCCCTTGCGGCCG
CATATTATGATCCTCTAGATCAGATC
Table S3. List of primers used in this study
TableS3
SUPPLEMENTAL INFORMATION 1 
SUPPLEMENTAL FIGURE LEGENDS 2 
Figure S1. A genetic screen identifies a sleep-promoting role for NPY and zebrafish npy is 3 
widely expressed in the brain (Related to Figure 1). (A) Histogram depicting the total amount 4 
of sleep during the night after heat shock for ~1200 human genes tested in the larval zebrafish 5 
genetic screen. Larvae overexpressing human NPY had a Z-score of 1.8. Overexpression of 6 
human NPY decreased locomotor activity (B-D) and increased sleep (E-G) compared to EGFP-7 
overexpressing controls during the night following heat shock (indicated by yellow bar). (H) Amino 8 
acid sequence alignment of human (Hs), mouse (Mm) and zebrafish (Dr) NPY mature peptide 9 
sequences. Colors indicate residues with similar properties. (I-L) ISH using an npy-specific probe 10 
reveals discrete yet widespread nuclei of npy expression in a 6-dpf zebrafish. Images show 4 11 
different focal planes, with the most dorsal image at left. The full image stack of npy expression 12 
throughout the brain mapped onto the Z-brain atlas is shown in Video S1. (M,N) Schematic 13 
drawings illustrate relative positions of different npy-expressing populations in ventral (M) and 14 
lateral (N) views. npy is expressed in the olfactory bulb (a), telencephalon (b), preoptic area (c), 15 
posterior tuberculum (d), Intermediate lateral hypothalamus (e), caudal medial hypothalamus (f), 16 
pretectum (g), torus semicircularis (h), tectum (i), locus coeruleus (j), medial rhombomere (k) and 17 
subpallium (l). a, anterior; p, posterior; d, dorsal; v, ventral. Scale bar: 100 µm. Mean (B,E) and 18 
mean ± SEM (C,D,F,G) are shown. n=number of animals. *P<0.05, **P<0.01 by two-tailed 19 
Student’s t test. 20 
 21 
Figure S2. NPY overexpression increases sleep at night and during subjective day in 22 
constant dark (Related to Figure 1). (A-J) Heat shock-induced overexpression of zebrafish NPY 23 
during the last hour of the day resulted in decreased locomotor activity (A-C) and increased sleep 24 
(D-F) during the following night. NPY overexpression increased the length of sleep bouts (H) and 25 
decreased the length of wake bouts (J), but did not affect the number of sleep bouts (G). Pre-HS 26 
Supplemental Data
and Post-HS quantify data during the entire day before and entire night after heat shock (indicated 27 
by yellow bar in line graphs), respectively. (K-Q) Larvae were entrained in 14:10 hour light:dark 28 
cycles for 4 days, and then transferred to constant dark after the fourth night of development. 29 
Heat shock-induced overexpression of zebrafish NPY during the subjective day resulted in 30 
decreased locomotor activity (K,L) and increased sleep (M,N) during the remainder of the 31 
subjective day. NPY overexpression increased the number of sleep bouts (O) and decreased the 32 
length of wake bouts (Q), but had no effect on the length of sleep bouts (P). Pre-HS and Post-HS 33 
quantify data during the entire subjective day before and after heat shock (indicated by yellow bar 34 
in line graphs), respectively. Mean ± SEM from 3 (A-J) and 2 (K-Q) pooled experiments are 35 
shown. n=number of animals. **** P<0.0001 by two-tailed Student’s t test. 36 
 37 
Figure S3. Loss of npy reduces daytime sleep in animals raised in LD before transition to 38 
LL (Related to Figure 3). Larvae were entrained in 14:10 hour LD cycles for 4 days and then 39 
behaviorally monitored for one LD cycle before transferring to LL. During the one LD cycle, npy-40 
/- larvae were more active (A), and slept less (C), than their npy+/+ and npy+/- siblings during the 41 
day. These phenotypes were due to fewer sleep bouts (E), and longer wake bouts (I). Mean ± 42 
SEM from 3 pooled experiments is shown. n=number of animals. *P<0.05, **P<0.01 by one-way 43 
ANOVA with Holm-Sidak post hoc test. 44 
 45 
Figure S4. The npy:kalta4 and uas:nfsb-mcherry transgenes do not affect sleep/wake 46 
behaviors (Related to Figure 4). Tg(npy:kalta4), Tg(uas:nfsb-mcherry) and WT sibling larvae 47 
were treated with MTZ from 3-5 dpf, and their behavior was monitored from the morning of 6 dpf 48 
until the morning of 8 dpf. Mean ± SEM from 3 pooled experiments is shown. n=number of 49 
animals. No significant difference was observed among the three genotypes in their activity (A-50 
C) or sleep (D-F) (P>0.05 by one-way ANOVA with Holm-Sidak post hoc test). 51 
 52 
Figure S5. Specific expression of kalta4 in npy-expressing neurons and TUNEL labeling of 53 
apoptotic cells (Related to Figure 4). (A) Double FISH showing kalta4 and npy co-expression 54 
using probes specific for kalta4 and npy in different populations of npy-expressing neurons. (B-55 
D) Tg(npy:kalta4);Tg(uas:nfsb-mcherry) animals were treated with DMSO (B) or 10 mM MTZ 56 
(C,D) from 72-90 hpf, and then fixed and processed for TUNEL. TUNEL labeling was observed in 57 
npy-expressing neurons of animals treated with MTZ (C,D), but not in animals treated with DMSO 58 
(B). Note that mCherry fluorescence is weaker in MTZ-treated animals because the neurons are 59 
undergoing apoptosis. Leftmost panels show schematic brain diagrams with npy expression 60 
domains colored as in Figure S1, and boxes indicate exemplar regions shown in the fluorescent 61 
images. a, anterior; p, posterior. Scale bar: 10 µm. 62 
 63 
Figure S6. The sedating effects of NPY overexpression and inhibition of NE signaling are 64 
not additive (Related to Figure 6). Tg(hsp:npy) larvae and their WT siblings were treated with 65 
100 µM prazosin or DMSO vehicle control, and then heat shocked (yellow bar in line graphs) 66 
during the fifth day of development. Prazosin-treated animals were less active (A,B) and slept 67 
more (C,D) during the day before and after heat shock. DMSO-treated Tg(hsp:npy) animals were 68 
less active and slept more than their DMSO-treated WT siblings during the day after heat shock. 69 
NPY overexpression did not further decrease locomotor activity or increase sleep in prazosin-70 
treated Tg(hsp:npy) animals. Pre-HS and Post-HS quantify data for day 5 before and after heat 71 
shock, respectively. Mean ± SEM from 3 pooled experiments is shown. n=number of animals. 72 
n.s.=not significant, *P<0.05, ****P<0.0001 by two-way ANOVA with Holm-Sidak post hoc test. 73 
 74 
Figure S7. Melatonin treatment enhances sleep induced by overexpression of NPY or by 75 
treatment with prazosin (Related to Figure 6). (A-D) Tg(hsp:npy) animals and their WT siblings 76 
were heat shocked (yellow bar in line graphs) during the fifth day of development, after which 20 77 
µM melatonin was added (arrow in line graphs). Tg(hsp:npy) animals were less active (A,B) and 78 
slept more (C,D) than their WT siblings after heat shock. Both Tg(hsp:npy) and their WT siblings 79 
showed a further decrease in activity (A,B) and increase in sleep (C,D) after addition of melatonin. 80 
Pre-HS and Post-HS quantify data for day 5 before and after heat shock, respectively. (E-H) WT 81 
animals were treated with either 100 µM prazosin or DMSO vehicle control starting at 4 dpf, and 82 
20 µM melatonin was added during the fifth day of development (arrow in line graphs). Prazosin-83 
treated animals were less active (E,F) and slept more (G,H) than DMSO-treated siblings. Both 84 
prazosin- and DMSO-treated animals showed a further decrease in activity (E,F) and increase in 85 
sleep (G,H) following addition of melatonin. Pre melatonin and Post melatonin quantify data for 86 
day 5 before and after addition of melatonin, respectively. Mean ± SEM for 2 (A-D) and 3 (E-H) 87 
pooled experiments are shown. n=number of animals. *P<0.05, ****P<0.0001 by two-way ANOVA 88 
with Holm-Sidak post hoc test. 89 
 90 
Table S1. Percentage of npy-expressing cells that express kalta4 in Tg(npy:kalta4) larvae 91 
(Related to Figure 4). The specificity of kalta4 expression in Tg(npy:kalta4) animals at 5 dpf was 92 
assayed by double FISH using probes specific for kalta4 and npy and quantified in each sub-93 
population of npy-expressing neurons. Mean ± SEM percentage of co-expression in 4 animals is 94 
shown. 95 
 96 
Table S2. Mutants tested for effects on NPY overexpression-induced sleep (Related to 97 
Figure 6). The effect of NPY overexpression on locomotor activity and sleep was compared in 98 
animals that were homozygous mutant for each of the indicated genes to their WT siblings. In 99 
each case an additive phenotype was observed. 100 
 101 
Table S3. List of primers used in this study. 102 
 103 
Video S1. Annotation of npy expression domains in the zebrafish brain (Related to Figure 104 
1). In situ hybridization with an npy-specific probe was performed on 6 dpf larval zebrafish brains, 105 
followed by immunostaining for t-ERK. The t-ERK staining was then used to register npy 106 
expression to the Z-brain reference brain. Anatomical domains of npy expression were then 107 
added using the Z-Brain browser annotations. Anterior is to the left and the video starts from the 108 
ventral surface of the brain. The video does not show the expression of npy expression in the 109 
olfactory bulb or retina. 110 
 111 
Video S2. Hindbrain npy-expressing neurons project to the LC (Related to Figure 5). 112 
Projections from hindbrain npy-expressing neurons (blue) and dbh-expressing LC neurons 113 
(yellow) form close contacts. An exemplar npy-expressing neuron (hightlighted magenta) appears 114 
to contact a single dbh-expressing neuron (highlighted green) at least twice (white, indicated by 115 
asterisk, magnified 4-fold in insets). Scale bar: 10 µm. 116 
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